Absci (ABSI) Operating Expenses (2020 - 2026)
Absci's (ABSI) quarterly Operating Expenses came in at $31.1 million in Q1 2026, up 7.45% year-on-year from $28.9 million in Q1 2025, and down 1.99% quarter-over-quarter from $31.7 million in Q4 2025.
Absci (ABSI) Operating Expenses (2020 - 2026) Analysis & Trends
Absci has disclosed Operating Expenses across 7 years of filings, most recently posting $31.1 million for Q1 2026.
- Operating Expenses for Q1 2026 came in at $31.1 million, up 7.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $125.3 million (up 6.22% YoY), and the FY2025 annual result was $123.1 million, up 8.55% from the prior year.
- Operating Expenses came in at $31.1 million for Q1 2026 at Absci, down from $31.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $46.4 million in Q2 2023 to a low of $22.6 million in Q4 2022.
- The 5-year median for Operating Expenses is $29.9 million (2022), against an average of $29.5 million.
- Across the five-year window, Operating Expenses soared 142.58% in 2022 and sank 39.62% in 2024, its largest moves.
- Absci's Operating Expenses stood at $22.6 million in 2022, then gained by 10.72% to $25.1 million in 2023, then gained by 21.38% to $30.4 million in 2024, then climbed by 4.11% to $31.7 million in 2025, then dropped by 1.99% to $31.1 million in 2026.
- The last three Operating Expenses figures came in at $31.1 million (Q1 2026), $31.7 million (Q4 2025), and $30.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 31.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.06 Mn |
| Dec 31, 2025 | 31.69 Mn |
| Sep 30, 2025 | 30.53 Mn |
| Jun 30, 2025 | 31.99 Mn |
| Mar 31, 2025 | 28.91 Mn |
| Dec 31, 2024 | 30.44 Mn |
| Sep 30, 2024 | 30.60 Mn |
| Jun 30, 2024 | 27.99 Mn |
| Mar 31, 2024 | 24.40 Mn |
| Dec 31, 2023 | 25.08 Mn |
| Sep 30, 2023 | 24.05 Mn |
| Jun 30, 2023 | 46.36 Mn |
| Mar 31, 2023 | 25.75 Mn |
| Dec 31, 2022 | 22.65 Mn |
| Sep 30, 2022 | 30.34 Mn |
| Jun 30, 2022 | 29.89 Mn |
| Mar 31, 2022 | 29.62 Mn |
| Dec 31, 2021 | 27.71 Mn |
| Sep 30, 2021 | 22.68 Mn |
| Jun 30, 2021 | 17.42 Mn |